3gga: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:3gga.png|left|200px]] | |||
[[Image:3gga. | |||
{{STRUCTURE_3gga| PDB=3gga | SCENE= }} | {{STRUCTURE_3gga| PDB=3gga | SCENE= }} | ||
===HIV Protease inhibitors with pseudo-symmetric cores=== | ===HIV Protease inhibitors with pseudo-symmetric cores=== | ||
{{ABSTRACT_PUBMED_19323562}} | {{ABSTRACT_PUBMED_19323562}} | ||
==About this Structure== | ==About this Structure== | ||
[[3gga]] is a 6 chain structure of [[Virus protease]] with sequence from [http://en.wikipedia.org/wiki/Human_immunodeficiency_virus_1 Human immunodeficiency virus 1]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3GGA OCA]. | |||
==See Also== | |||
*[[Virus protease|Virus protease]] | |||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID: | <ref group="xtra">PMID:019323562</ref><references group="xtra"/> | ||
[[Category: Human immunodeficiency virus 1]] | [[Category: Human immunodeficiency virus 1]] | ||
[[Category: Stoll, V S.]] | [[Category: Stoll, V S.]] | ||
| Line 29: | Line 20: | ||
[[Category: Protease]] | [[Category: Protease]] | ||
[[Category: Pseudo-symmetrical hiv protease inhibitor]] | [[Category: Pseudo-symmetrical hiv protease inhibitor]] | ||
Revision as of 15:27, 27 July 2012
HIV Protease inhibitors with pseudo-symmetric cores
Template:ABSTRACT PUBMED 19323562
About this Structure
3gga is a 6 chain structure of Virus protease with sequence from Human immunodeficiency virus 1. Full crystallographic information is available from OCA.
See Also
Reference
- Degoey DA, Grampovnik DJ, Flentge CA, Flosi WJ, Chen HJ, Yeung CM, Randolph JT, Klein LL, Dekhtyar T, Colletti L, Marsh KC, Stoll V, Mamo M, Morfitt DC, Nguyen B, Schmidt JM, Swanson SJ, Mo H, Kati WM, Molla A, Kempf DJ. 2-Pyridyl P1'-substituted symmetry-based human immunodeficiency virus protease inhibitors (A-792611 and A-790742) with potential for convenient dosing and reduced side effects. J Med Chem. 2009 Apr 23;52(8):2571-86. PMID:19323562 doi:https://dx.doi.org/10.1021/jm900044w
